Equity Research firms currently have a positive stance on shares of WaferGen Bio-systems, Inc. (NASDAQ:WGBS). The majority of analysts covering the equity have a consensus Strong Buy recommendation on the stock, yielding a score of 1.00. This is based on the research brokerage reports taken into consideration by Thomson Reuters. Those same analysts are projecting that the stock will reach $1.50 on a short term basis.
At the time of writing, the stock was trading at $0.84. This represents a change from the opening price of -1.66%. In terms of performance, year to date, the stock is 14.73%. The monthly stock performance comes in at 1.03%. For the quarter, shares are performing at 2.13%. Weekly performance analysis shows the equity at 1.48%.
In taking a look at technical levels, shares are trading -7.85% away from the 50 day simple moving average and 9.29% away from the 200 day simple moving average. Based on a recent bid, the stock is trading -68.81% away from it’s 52- week high and 81.72% away from its 52 week low. After the recent moves, investors may also look to see if the stock has entered oversold or overbought territory and could be ripe for a bounce. As of writing, WaferGen Bio-systems, Inc.’s RSI stands at 44.54. In looking at volatility levels, the shares saw weekly volatility of 4.70% and 4.71% over the past month.